C

Celsius Therapeutics

64 employees

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Emergency Medicine
Genomic Analysis
Immuno-Oncology
Oncology
Single-cell RNA Sequencing
Computational Genomics
Perturb-Seq
Health Care
Genetics
Autoimmune
Drug Combinations
Precision Medicine

Date founded

2018

Funding rounds raised

Total raised

$83M

from 13 investors over 13 rounds

C

Celsius Therapeutics raised $83M on March 24, 2022

Investors: Heritage Physician Networks, 苏州凯风正德投资管理有限公司, Catalio Capital Management, Third Rock Ventures, Section 32, GV, Casdin Capital, LLC, Amplitude Ventures and Fast Track Initiative

C

Celsius Therapeutics raised $65M on May 15, 2018

Investors: Heritage Physician Networks, Third Rock Ventures, GV and Casdin Capital, LLC

FAQ